Heavier individuals may require higher doses to achieve equivalent NNMT inhibition due to larger adipose tissue mass and potentially higher baseline NNMT activity
However, those with active cancer are generally advised to avoid these compounds [4, 5]
Comparative analysis of structural properties When comparing the molecular structures of SLU-PP-332 and 5-amino-1mq, several key differences emerge: Size and complexity: SLU-PP-332 generally has a larger and more complex structure compared to 5-amino-1mq
Customers are responsible for ensuring compliance with local laws prior to ordering.
Any misrepresentation of intended use may lead to regulatory or legal consequences
The winner will depend on Phase 3 data, tolerability, approval timing, label breadth, payer access, and real-world persistence